Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Biliary Tract Cancer - Summit Therapeutics Oncodaily
In a new paper published in Cell Reports Medicine, the UCL team outlines how they, in collaboration with a University of Cambridge team, developed a new type of treatment-predicting computer program that uses an individual's detailed genetic fingerprint to explore which treatments, if any, may kill their…
Искусственный интеллект научился лечить самую агрессивную форму рака груди RTVI
Seek Labs Expands Oncology Research for Sequence Ablation Therapeutics with Up to $3 Million in Foundation Support Yahoo Finance
Препарат Hansoh и GSK продлил жизнь пациентам с раком костей Investing.com
Обнаружен эффективный способ борьбы с распространенным видом рака кишечника Версии.сом
Merck drug extends survival in endometrial cancer trial, wins US priority review KSL News
Machine learning models using routinely collected health information, such as blood tests, medical history and lifestyle factors, could help identify people at higher risk of several common cancers, according to an international study reported at the ESMO Congress 2026.
An immunotherapy-based regimen combining durvalumab and the PARP inhibitor olaparib demonstrated encouraging long-term survival outcomes for patients with advanced or recurrent endometrial cancer, according to new trial results presented by researchers from The University of Texas MD Anderson Cancer Center.
ESMO 2026: Merck’s Kelun-partnered ADC cuts death risk by over 30% in endometrial cancer BioSpace
Network aims to expand clinical trial access for myeloma patients Rare Cancer News
A new drug shows efficacy against advanced endometrial cancer, according to a phase 3 trial Science Media Centre España
Merck Drug Boosts Survival From Hard-to-Treat Uterine Cancer Yahoo Finance UK
